Finemedix Co., Ltd. (KOSDAQ:387570)

Finemedix Statistics

Total Valuation

Finemedix has a market cap or net worth of KRW 42.36 billion. The enterprise value is 39.78 billion.

Market Cap	42.36B
Enterprise Value	39.78B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Finemedix has 5.43 million shares outstanding. The number of shares has increased by 9.11% in one year.

Current Share Class	5.43M
Shares Outstanding	5.43M
Shares Change (YoY)	+9.11%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	37.29%
Owned by Institutions (%)	n/a
Float	2.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.00
PB Ratio	2.19
P/TBV Ratio	2.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 207.70, with an EV/FCF ratio of -12.40.

EV / Earnings	-68.74
EV / Sales	3.75
EV / EBITDA	207.70
EV / EBIT	n/a
EV / FCF	-12.40

Financial Position

The company has a current ratio of 6.78, with a Debt / Equity ratio of 0.14.

Current Ratio	6.78
Quick Ratio	4.20
Debt / Equity	0.14
Debt / EBITDA	14.61
Debt / FCF	-0.87
Interest Coverage	-7.38

Financial Efficiency

Return on equity (ROE) is -3.70% and return on invested capital (ROIC) is -2.60%.

Return on Equity (ROE)	-3.70%
Return on Assets (ROA)	-2.37%
Return on Invested Capital (ROIC)	-2.60%
Return on Capital Employed (ROCE)	-3.58%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.51
Inventory Turnover	1.20

Taxes

Income Tax	-441.84M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	8,142.20
200-Day Moving Average	8,363.35
Relative Strength Index (RSI)	43.62
Average Volume (20 Days)	66,544

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Finemedix had revenue of KRW 10.60 billion and -578.67 million in losses. Loss per share was -115.74.

Revenue	10.60B
Gross Profit	5.72B
Operating Income	-794.35M
Pretax Income	-1.02B
Net Income	-578.67M
EBITDA	191.51M
EBIT	-794.35M
Loss Per Share	-115.74

Balance Sheet

The company has 5.38 billion in cash and 2.80 billion in debt, giving a net cash position of 2.58 billion or 475.42 per share.

Cash & Cash Equivalents	5.38B
Total Debt	2.80B
Net Cash	2.58B
Net Cash Per Share	475.42
Equity (Book Value)	19.30B
Book Value Per Share	3,554.52
Working Capital	11.45B

Cash Flow

In the last 12 months, operating cash flow was -2.38 billion and capital expenditures -833.23 million, giving a free cash flow of -3.21 billion.

Operating Cash Flow	-2.38B
Capital Expenditures	-833.23M
Free Cash Flow	-3.21B
FCF Per Share	-590.89

Margins

Gross margin is 53.98%, with operating and profit margins of -7.50% and -5.46%.

Gross Margin	53.98%
Operating Margin	-7.50%
Pretax Margin	-9.63%
Profit Margin	-5.46%
EBITDA Margin	1.81%
EBIT Margin	-7.50%
FCF Margin	n/a

Dividends & Yields

Finemedix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.11%
Shareholder Yield	-9.11%
Earnings Yield	-1.37%
FCF Yield	-7.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Finemedix has an Altman Z-Score of 6.9 and a Piotroski F-Score of 2.

Altman Z-Score	6.9
Piotroski F-Score	2